MetLife, 5.875% Senior Notes due 11/21/2033 (MLG)

EBITDA

$1.33B

Quarterly · Period ending: · USD

MLG logo

MLG EBITDA

Latest reported$1.33B
MLG Quarterly EBITDA (-$232.00M → $1.33B)
High-resolution chart · PNG

MLG ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

MetLife, 5.875% Senior Notes due 11/21/2033 EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
1,327,000,000
1,772,000,000
1,380,000,000
1,481,000,000
1,249,000,000
1,612,000,000
1,640,000,000
2,251,000,000
1,459,000,000
1,309,000,000
1,210,000,000
799,000,000
686,000,000
512,000,000
1,975,000,000
1,654,000,000
1,214,000,000
2,160,000,000
1,530,000,000
2,282,000,000
4,715,000,000
519,000,000
394,000,000
1,152,000,000
429,000,000
5,865,000,000
187,000,000
3,014,000,000
2,571,000,000
1,978,000,000
2,731,000,000
1,346,000,000
1,410,000,000
1,942,000,000
1,332,000,000
769,000,000
1,302,000,000
1,355,000,000
-3,274,000,000
1,439,000,000
206,000,000
3,234,000,000
1,435,000,000
2,465,000,000
1,421,000,000
3,357,000,000
2,373,000,000
3,247,000,000
2,262,000,000
2,138,000,000
1,591,000,000
1,293,000,000
882,000,000
1,568,000,000
-129,000,000
-665,000,000
3,700,000,000
-30,000,000
1,258,000,000
5,566,000,000
1,953,000,000
1,723,000,000
-308,000,000
815,000,000
2,768,000,000
1,594,000,000
179,000,000
-854,000,000
-2,245,000,000
-833,000,000
1,182,000,000
1,852,000,000
1,334,000,000
2,718,000,000
1,886,000,000
1,587,000,000
1,900,000,000
3,071,000,000
1,296,000,000
1,560,000,000
1,050,000,000
1,257,000,000
1,000,000,000
1,155,000,000
1,592,000,000
1,281,000,000
726,000,000
1,092,000,000
1,158,000,000
996,000,000
727,000,000
694,000,000
784,000,000
410,000,000
208,000,000
438,000,000
486,000,000
493,000,000
-420,000,000
86,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.